MENU
SABS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
SAB Biotherapeutics (SABS) Ownership - Who owns SAB Biotherapeutics?
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum... Show more
Profile
Industry
N/A
Address
2100 East 54th Street North
Phone
+1 605 679-6980
Employees
57
Web
https://www.sabbiotherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
15.88M
P/E Ratio
N/A
Total Cash
12.85M
Projected Growth
N/A
Total Debt
6.78M
Revenue
N/A
Risk (Beta)
0.52
Dividend Yield
N/A
Total Cash/Share
1.38
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
SABS
Capitalization
15.9M
P/E Ratio
N/A
Risk (Beta)
0.52
Dividend Yield
N/A
Total Cash
12.9M
Total Cash/Share
1.38
Total Debt
6.78M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
21.4M
P/B Ratio
0.74
Cash Flow
N/A
Earnings
-3.7
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
936
Current Ratio
1.69
Current Revenue Per Employee
10376.80
Dividends Per Share - Security
N/A
EBITDA
-30.38M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-62.61
Shares Held By Institutions
3.88M
Shares Outstanding - Current
9.29M
Total Liabilities
16.7M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-54.931
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2100 East 54th Street North
Phone
+1 605 679-6980
Employees
57
Web
https://www.sabbiotherapeutics.com